The US Centers for Disease and Prevention (CDC) no longer recommends that all US newborns receive the hepatitis B vaccine, ...

GSK's Exdensur (depemokimab) is now the first FDA-approved, twice-yearly add-on maintenance therapy for severe eosinophilic asthma.

Targeted patient recruitment can increase the likelihood of trial success and help cultivate use of precision medicine.

Harbour BioMed and Bristol Myers Squibb (BMS) have signed a multi-year, worldwide strategic partnership and licence agreement ...

INCOG BioPharma Services has announced an injectable drug manufacturing expansion at its Fishers facility in Indiana, US.

Cellular Origins is a UK‑based company enabling scalable, factory‑led automation for cell and gene therapy manufacturing, and ...

Sino Biological, Inc., a global leader in biological reagents and CRO services, recently announced that it has been honoured with the “2025 Supplier Performance Recognition Award” by Scientist.com.

BostonGene has won four awards in the Research & Development, Product Launches, and Innovation categories in the 2025 ...

Sanofi has agreed $1.7bn and $1.04bn licensing deals with Dren Bio and ADEL, respectively. Following the disappointment of a ...

Amid profit forecast reductions, Pfizer is implementing a $7.7bn cost-cutting strategy, while investing into its ...

Large deals in H2 2025 included Novartis’ $12 billion acquisition of Avidity Biosciences and Genmab’s buyout of Merus, ...

With a lack of radiologists around the world, targeted uses of AI in Scotland are creating efficiencies in medical imaging.